169 related articles for article (PubMed ID: 1574960)
1. Recombinant human erythropoietin in patients with ovarian carcinoma and anaemia secondary to cisplatin and carboplatin chemotherapy: preliminary results.
James RD; Wilkinson PM; Belli F; Welch R; Cowan R
Acta Haematol; 1992; 87 Suppl 1():12-5. PubMed ID: 1574960
[TBL] [Abstract][Full Text] [Related]
2. The effect of subcutaneous recombinant human erythropoietin (r-HuEPO) on anemia in cancer patients receiving platinum-based chemotherapy.
Malik IA; Khan ZK; Hakimali A; Sabih M; Rehman G
J Pak Med Assoc; 1998 May; 48(5):127-31. PubMed ID: 9813972
[TBL] [Abstract][Full Text] [Related]
3. Recombinant human erythropoietin in the treatment of the anaemia of cancer.
Abels RI
Acta Haematol; 1992; 87 Suppl 1():4-11. PubMed ID: 1574966
[TBL] [Abstract][Full Text] [Related]
4. Double-blind randomized control trial of the effect of recombinant human erythropoietin on chemotherapy-induced anemia in patients with non-small cell lung cancer.
Kunikane H; Watanabe K; Fukuoka M; Saijo N; Furuse K; Ikegami H; Ariyoshi Y; Kishimoto S
Int J Clin Oncol; 2001 Dec; 6(6):296-301. PubMed ID: 11828949
[TBL] [Abstract][Full Text] [Related]
5. Recombinant human erythropoietin therapy for anemic cancer patients receiving cisplatin chemotherapy.
Henry DH; Brooks BJ; Case DC; Fishkin E; Jacobson R; Keller AM; Kugler J; Moore J; Silver RT; Storniolo AM; Abels RI; Gordon DS; Nelson R; Larholt K; Bryant E; Rudnick S
Cancer J Sci Am; 1995; 1(4):252-60. PubMed ID: 9166485
[TBL] [Abstract][Full Text] [Related]
6. Controlled multicentre study of the influence of subcutaneous recombinant human erythropoietin on anaemia and transfusion dependency in patients with ovarian carcinoma treated with platinum-based chemotherapy.
ten Bokkel Huinink WW; de Swart CA; van Toorn DW; Morack G; Breed WP; Hillen HF; van der Hoeven JJ; Reed NS; Fairlamb DJ; Chan SY; Godfrey KA; Kristensen GB; van Tinteren H; Ehmer B
Med Oncol; 1998 Sep; 15(3):174-82. PubMed ID: 9819794
[TBL] [Abstract][Full Text] [Related]
7. Recombinant human erythropoietin treatment: investigational new drug protocol for the anemia of the acquired immunodeficiency syndrome. Overall results.
Phair JP; Abels RI; McNeill MV; Sullivan DJ
Arch Intern Med; 1993 Dec; 153(23):2669-75. PubMed ID: 8250662
[TBL] [Abstract][Full Text] [Related]
8. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: final report of a randomized, open-labelled, phase II trial.
Sweeney PJ; Nicolae D; Ignacio L; Chen L; Roach M; Wara W; Marcus KC; Vijayakumar S
Br J Cancer; 1998 Jun; 77(11):1996-2002. PubMed ID: 9667681
[TBL] [Abstract][Full Text] [Related]
9. Erythropoietin increases hemoglobin during radiation therapy for cervical cancer.
Dusenbery KE; McGuire WA; Holt PJ; Carson LF; Fowler JM; Twiggs LB; Potish RA
Int J Radiat Oncol Biol Phys; 1994 Jul; 29(5):1079-84. PubMed ID: 8083076
[TBL] [Abstract][Full Text] [Related]
10. [Recombinant human erythropoietin in the treatment of anemic patients undergoing chemotherapy for cancer].
Bösze P; Mayer A; Thurzó L; Kiss A; Rák K; Stumpf J
Orv Hetil; 1995 Nov; 136(47):2567-72. PubMed ID: 8532322
[TBL] [Abstract][Full Text] [Related]
11. Erythropoietin reduces anemia and transfusions after chemotherapy with paclitaxel and carboplatin.
Dunphy FR; Dunleavy TL; Harrison BR; Boyd JH; Varvares MA; Dunphy CH; Rodriguez JJ; McDonough EM; Minster JR; McGrady MD
Cancer; 1997 Apr; 79(8):1623-8. PubMed ID: 9118049
[TBL] [Abstract][Full Text] [Related]
12. Phase III trial to evaluate the efficacy of maintaining hemoglobin levels above 12.0 g/dL with erythropoietin vs above 10.0 g/dL without erythropoietin in anemic patients receiving concurrent radiation and cisplatin for cervical cancer.
Thomas G; Ali S; Hoebers FJ; Darcy KM; Rodgers WH; Patel M; Abulafia O; Lucci JA; Begg AC
Gynecol Oncol; 2008 Feb; 108(2):317-25. PubMed ID: 18037478
[TBL] [Abstract][Full Text] [Related]
13. The effect of subcutaneous r-HuEPO in cancer patients receiving chemotherapy with anemia: a preliminary report.
Chiou TJ; Chim YS; Wei CH; Hsieh RK; Chen PM
Zhonghua Yi Xue Za Zhi (Taipei); 1997 Nov; 60(5):229-35. PubMed ID: 9509677
[TBL] [Abstract][Full Text] [Related]
14. Incidence of symptomatic deep venous thrombosis with epoetin alfa or darbepoetin alfa treatment of anemia in patients with ovarian or primary peritoneal cancer.
Westin SN; Skinner EN; Jonsson Funk M; Gehrig PM; Van Le L
Gynecol Oncol; 2007 May; 105(2):414-7. PubMed ID: 17250880
[TBL] [Abstract][Full Text] [Related]
15. Identification of risk factors for requiring transfusion during front-line chemotherapy for ovarian cancer.
Hensley ML; Lebeau D; Leon LF; Venkatraman E; Waltzman R; Sabbatini P; Almadrones L; Chi D; Spriggs D
Gynecol Oncol; 2001 Jun; 81(3):485-9. PubMed ID: 11371143
[TBL] [Abstract][Full Text] [Related]
16. Treatment of the anemia of predialysis patients with recombinant human erythropoietin: a randomized, placebo-controlled trial.
Stone WJ; Graber SE; Krantz SB; Dessypris EN; O'Neil VL; Olsen NJ; Pincus TP
Am J Med Sci; 1988 Sep; 296(3):171-9. PubMed ID: 3177433
[TBL] [Abstract][Full Text] [Related]
17. Current use of recombinant human erythropoietin (r-huEPO) in the management of symptomatic anaemia in patients with myelodysplastic syndromes (MDS).
Marques da Costa R
Sangre (Barc); 1994 Apr; 39(2):105-10. PubMed ID: 8059287
[TBL] [Abstract][Full Text] [Related]
18. Clinical and in vitro effects of recombinant human erythropoietin in patients receiving intensive chemotherapy for small-cell lung cancer.
de Campos E; Radford J; Steward W; Milroy R; Dougal M; Swindell R; Testa N; Thatcher N
J Clin Oncol; 1995 Jul; 13(7):1623-31. PubMed ID: 7602351
[TBL] [Abstract][Full Text] [Related]
19. The use of recombinant human erythropoietin to prevent carboplatin-induced anemia.
Markman M; Reichman B; Hakes T; Rubin S; Jones W; Lewis JL; Barakat R; Curtin J; Almadrones L; Hoskins W
Gynecol Oncol; 1993 May; 49(2):172-6. PubMed ID: 8504984
[TBL] [Abstract][Full Text] [Related]
20. Effect of subcutaneous recombinant human erythropoietin in cancer patients receiving radiotherapy: preliminary results of a randomized, open-labeled, phase II trial.
Vijayakumar S; Roach M; Wara W; Chan SK; Ewing C; Rubin S; Sutton H; Halpern H; Awan A; Houghton A
Int J Radiat Oncol Biol Phys; 1993 Jul; 26(4):721-9. PubMed ID: 8331011
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
